Dow Down 0.32% Nasdaq Down 0.62%

Pain Therapeutics Inc. (PTIE)

-NasdaqGS
2.42 Down 0.07(2.81%) Apr 29, 3:58PM EDT
Prev Close:2.49
Open:2.49
Bid:2.06 x 4100
Ask:2.55 x 100
1y Target Est:6.00
Beta:1.70417
Earnings Date:May 5 - May 9 (Est.)
Day's Range:2.35 - 2.54
52wk Range:1.53 - 3.65
Volume:77,170
Avg Vol (3m):106,741
Market Cap:110.73M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTIE

Comparison

Symbol% ChgMkt Cap
PTIEDown 2.81%110.73M
ABTDown 3.76%57.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.56
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company’s lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback